We Ran for Fun Through Hyde Park!

June 2004

7th June 2004We Ran for Fun Through Hyde Park!

[Runners in Hyde park]

Four Richmond Pharmacology managers braved the recent 10k Capital FM Bupa Featbeat fun run through Hyde Park! Sarah Willison, Victoria Blades, Chris Robinson and Sian Dale took part in the fund raising event, held on 23 May 2004.Our runners joined 7,000 other fun runners to raise money for Help a London Child. The run started at the Prince of Wales Gate in Hyde Park, taking runners along New Ride and up to Hyde Park Corner. Runners then ran past Grosvenor Gate and around the The Ring to The Serpentine lake. At which point, runners had to turnaround and run all the way back again!Victoria, Head of Clinical Project Management, commented “I felt fine until we reached The Serpentine but then my heart sank when I realized we had to run all the way back again! I think I need to take the training a bit more seriously before the next fun run!”Sarah Willison, Senior Project Manager, added “The last two miles didn’t feel fun! It was a great atmosphere though – the crowd were fantastic.”Richmond Pharmacology sponsored the four runners, donating £600 to the charity. They have already agreed to run the Windsor Half Marathon on 26 September 2004.Victoria commented: “Running over twice as far as we did in Hyde Park will certainly be a challenge! But its good to contribute in some small way to Help a London Child, so I had better get some training mileage done in the meantime!”For more information on events to raise funds for Help a London Child please visit www.capitalfm.com

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more